Thomas Engstrom
Clinical trials sponsored by Thomas Engstrom, explained in plain language.
-
Ambulance steroid shot may cut heart attack deaths by 23%
Disease control Recruiting nowThis study tests whether a single high-dose steroid (methylprednisolone) given in the ambulance before standard heart attack treatment can reduce death and heart failure in people having a severe type of heart attack (STEMI). About 5,200 participants will be randomly assigned to …
Phase: PHASE3 • Sponsor: Thomas Engstrom • Aim: Disease control
Last updated May 14, 2026 12:02 UTC
-
New heart attack techniques aim to save lives and prevent hospitalizations
Disease control Recruiting nowThis study tests two methods used during emergency heart attack treatment: ischemic postconditioning (briefly pausing blood flow after opening the artery) and ultrasound-guided stent placement. The goal is to see if these approaches reduce death, heart failure, or the need for re…
Phase: NA • Sponsor: Thomas Engstrom • Aim: Disease control
Last updated May 04, 2026 16:23 UTC
-
Heart attack study tests if delayed artery opening still saves heart muscle
Knowledge-focused Recruiting nowThis study looks at whether opening a blocked heart artery 12 to 36 hours after a heart attack can help the heart recover. It involves 150 stable patients who will be randomly assigned to get the procedure right away or wait a few days. The goal is to see if earlier treatment sav…
Phase: NA • Sponsor: Thomas Engstrom • Aim: Knowledge-focused
Last updated May 17, 2026 05:07 UTC